Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed.

Click here for more...
from #Bangladesh #News aka Bangladesh News Now!!!